Big Data and Analytics

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the $2 trillion mark in 2020. Healthcare will be among the top two priorities for voters in the 2020 presidential election in the US. In the European region, looming BREXIT indecision is likely to have a strong impact o...

Femtech is an emerging term and, as is the case with most new concepts, is poorly understood. While some relate Femtech only with products unique to the female anatomy (including consumer products), others dismiss it as just another term for a group of existing solutions. Frost & Sullivan believes it is a unique space and a place for new growth opp...

28 Jan 2020  |  North America  |  Market Research

Global Healthcare Cloud Computing Market, Forecast to 2023

Competitive Dynamics are Pushing Services to the Forefront

Infographics

×

Key Issues Addressed

Cloud computing in healthcare is gaining momentum as a variety of factors create a significant need for the value propositions that a successful cloud implementation promises to offer. Global healthcare cloud market revenue is expected to surge at a compound annual growth rate of 25.1% from 2018 to 2023. Cloud computing involves the use of exter...

30 Jan 2020  |  North America  |  Market Research

Assessment of the US Revenue Cycle Management Market, Forecast to 2024

The Next Generation RCM is Prioritizing Consumer Centricity

Infographics

×

This study primarily strives to: • Analyze the market forces affecting the utilization of next-generation Revenue Cycle Management (RCM) IT and service solutions among US hospitals and physician practices. • Evaluate the latest regulatory objectives that mandate episodic financial risk management initiatives. • Highlight the best ...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

01 Jun 2020  |  North America  |  Market Research

Growth Opportunities in Artificial Intelligence and Analytics in Surgery, 2020

Landscape and Opportunity Assessment in an Emerging Area

Infographics

×

Key Issues Addressed

Artificial intelligence (AI) and analytics technologies are now being well accepted in healthcare, with bellwether clinical application areas (e.g., radiology), and operational application areas (e.g., revenue cycle management). One area of the hospital that perhaps needs the most attention, is the hospital operating room (OR). The OR is a hospital...

The ICU is the most data-intensive part of the hospital, as continuous monitoring of patient health generates a huge volume of crucial data valuable for clinical decision making and future research. With digitalization, it is now easy and efficient to use analytics and connectivity solutions to analyze this data and draw insights for better care de...

Precision medicine is transitioning toward wider acceptance, due to mounting payer pressures and regulatory changes that are shifting pharma businesses from prescriptive to more predictive and personalized models. Emergence of value-based reimbursement models and healthcare consumerism trends are helping move the treatment model from ‘one-size-fi...